{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:43:51Z","timestamp":1784025831316,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Foundation of the Guizhou Health Commission","award":["gzwkj2024-021"],"award-info":[{"award-number":["gzwkj2024-021"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860478"],"award-info":[{"award-number":["81860478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83719-3","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:44:55Z","timestamp":1735595095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration"],"prefix":"10.1038","volume":"14","author":[{"given":"Song","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"5","key":"83719_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid cancer. Rev. JAMA 331(5), 425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348 (2024).","journal-title":"Rev. JAMA"},{"issue":"7","key":"83719_CR2","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","volume":"37","author":"A Coca-Pelaz","year":"2020","unstructured":"Coca-Pelaz, A. et al. Papillary thyroid cancer-aggressive variants and impact on management: a narrative review. Adv. Ther. 37 (7), 3112\u20133128. https:\/\/doi.org\/10.1007\/s12325-020-01391-1 (2020).","journal-title":"Adv. Ther."},{"issue":"6","key":"83719_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"Cabanillas, M. E., Ryder, M. & Jimenez, C. Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr. Rev. 40 (6), 1573\u20131604. https:\/\/doi.org\/10.1210\/er.2019-00007 (2019).","journal-title":"Endocr. Rev."},{"issue":"1","key":"83719_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid 26 (1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"issue":"4","key":"83719_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF01758424","volume":"10","author":"A Blanchard","year":"1989","unstructured":"Blanchard, A., Ohanian, V. & Critchley, D. The structure and function of alpha-actinin. J. Muscle Res. Cell. Motil. 10 (4), 280\u2013289. https:\/\/doi.org\/10.1007\/BF01758424 (1989).","journal-title":"J. Muscle Res. Cell. Motil."},{"key":"83719_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13578-015-0029-7","volume":"5","author":"AC Murphy","year":"2015","unstructured":"Murphy, A. C. & Young, P. W. The actinin family of actin cross-linking proteins\u2014A genetic perspective. Cell. Biosci. 5, 49. https:\/\/doi.org\/10.1186\/s13578-015-0029-7 (2015).","journal-title":"Cell. Biosci."},{"issue":"1","key":"83719_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20131511","volume":"459","author":"KS Foley","year":"2014","unstructured":"Foley, K. S. & Young, P. W. The non-muscle functions of actinins: an update. Biochem. J. 459 (1), 1\u201313. https:\/\/doi.org\/10.1042\/BJ20131511 (2014).","journal-title":"Biochem. J."},{"issue":"11","key":"83719_CR8","doi-asserted-by":"publisher","first-page":"e13921","DOI":"10.1371\/journal.pone.0013921","volume":"5","author":"H Shao","year":"2010","unstructured":"Shao, H., Wang, J. H., Pollak, M. R. & Wells, A. \u03b1-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS ONE 5 (11), e13921. https:\/\/doi.org\/10.1371\/journal.pone.0013921 (2010).","journal-title":"PLoS ONE"},{"issue":"6","key":"83719_CR9","first-page":"3157","volume":"34","author":"N Anaka","year":"2014","unstructured":"Anaka, N. et al. Histological growth pattern of alpha-actinin-4 expression in thyroid cancer. Anticancer Res. 34 (6), 3157\u20133163 (2014).","journal-title":"Anticancer Res."},{"issue":"1","key":"83719_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-021-01383-x","volume":"20","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC. Mol. Cancer 20 (1), 91. https:\/\/doi.org\/10.1186\/s12943-021-01383-x (2021).","journal-title":"Mol. Cancer"},{"issue":"7","key":"83719_CR11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/carcin\/bgz168","volume":"41","author":"J Jung","year":"2020","unstructured":"Jung, J., Kim, S., An, H. T. & Ko, J. \u03b1-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer. Carcinogenesis 41 (7), 940\u2013949. https:\/\/doi.org\/10.1093\/carcin\/bgz168 (2020).","journal-title":"Carcinogenesis"},{"key":"83719_CR12","doi-asserted-by":"publisher","first-page":"1169833","DOI":"10.3389\/fonc.2023.1169833","volume":"13","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K\/AKT\/mTOR signaling pathway. Front. Oncol. 13, 1169833. https:\/\/doi.org\/10.3389\/fonc.2023.1169833 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"83719_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13046-023-02904-w","volume":"42","author":"L Cui","year":"2023","unstructured":"Cui, L., Lu, Y., Zheng, J., Guo, B. & Zhao, X. ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3\u03b2 and integrin \u03b21-mediated phosphorylation of FAK. J. Exp. Clin. Cancer Res. 42 (1), 335. https:\/\/doi.org\/10.1186\/s13046-023-02904-w (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"83719_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s44321-024-00050-0","volume":"16","author":"M Inayatullah","year":"2024","unstructured":"Inayatullah, M. et al. Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO Mol. Med. 16 (4), 823\u2013853. https:\/\/doi.org\/10.1038\/s44321-024-00050-0 (2024).","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"83719_CR15","doi-asserted-by":"publisher","first-page":"e0196986","DOI":"10.1371\/journal.pone.0196986","volume":"13","author":"B Kovac","year":"2018","unstructured":"Kovac, B., M\u00e4kel\u00e4, T. P. & Vallenius, T. Increased \u03b1-actinin-1 destabilizes e-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer. PLoS ONE 13 (5), e0196986. https:\/\/doi.org\/10.1371\/journal.pone.0196986 (2018).","journal-title":"PLoS ONE"},{"key":"83719_CR16","doi-asserted-by":"publisher","first-page":"104981","DOI":"10.1016\/j.phrs.2020.104981","volume":"159","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis. Pharmacol. Res. 159, 104981. https:\/\/doi.org\/10.1016\/j.phrs.2020.104981 (2020).","journal-title":"Pharmacol. Res."},{"issue":"5","key":"83719_CR17","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"\u00c1 Bartha","year":"2021","unstructured":"Bartha, \u00c1. & Gy\u0151rffy, B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. 22 (5), 2622. https:\/\/doi.org\/10.3390\/ijms22052622 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"83719_CR18","doi-asserted-by":"publisher","unstructured":"Stelzer, G. et al. The GeneCards suite: from gene data mining to disease genome sequence analysis. Curr. Protoc. Bioinform. 54, 30\u201333. https:\/\/doi.org\/10.1002\/cpbi.5 (2016).","DOI":"10.1002\/cpbi.5"},{"issue":"8","key":"83719_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19 (8), 649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002 (2017).","journal-title":"Neoplasia"},{"issue":"W1","key":"83719_CR20","doi-asserted-by":"publisher","first-page":"W561","DOI":"10.1093\/nar\/gkz445","volume":"47","author":"A Koch","year":"2019","unstructured":"Koch, A., Jeschke, J., Van Criekinge, W., van Engeland, M. & De Meyer, T. MEXPRESS update 2019. Nucleic Acids Res. 47 (W1), W561\u2013W565. https:\/\/doi.org\/10.1093\/nar\/gkz445 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"83719_CR21","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky, A. & Gy\u0151rffy, B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J. Med. Internet Res. 23 (7), e27633. https:\/\/doi.org\/10.2196\/27633 (2021).","journal-title":"J. Med. Internet Res."},{"issue":"D1","key":"83719_CR22","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar, S. V., Straub, P., Wang, J., Zhang, B. & Linkedomics Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 46 (D1), D956\u2013D963. https:\/\/doi.org\/10.1093\/nar\/gkx1090 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"83719_CR23","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77 (21), e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307 (2017).","journal-title":"Cancer Res."},{"issue":"20","key":"83719_CR24","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35 (20), 4200\u20134202. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210 (2019).","journal-title":"Bioinformatics"},{"issue":"3","key":"83719_CR25","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen, W. et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta 1 (3), e36. https:\/\/doi.org\/10.1002\/imt2.36 (2022).","journal-title":"Imeta"},{"issue":"W1","key":"83719_CR26","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res. 46 (W1), W60\u2013W64. https:\/\/doi.org\/10.1093\/nar\/gky311 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"83719_CR27","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"83719_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1471-2105-12-298","volume":"12","author":"ME Fahey","year":"2011","unstructured":"Fahey, M. E. et al. GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinform. 12, 298. https:\/\/doi.org\/10.1186\/1471-2105-12-298 (2011).","journal-title":"BMC Bioinform."},{"issue":"D1","key":"83719_CR29","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt Consortium","year":"2023","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 51 (D1), D523\u2013D531. https:\/\/doi.org\/10.1093\/nar\/gkac1052 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"83719_CR30","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S. Y. HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Res. 45 (W1), W365\u2013W373. https:\/\/doi.org\/10.1093\/nar\/gkx407 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"83719_CR31","doi-asserted-by":"publisher","first-page":"166591","DOI":"10.1016\/j.bbadis.2022.166591","volume":"1869","author":"Z Pan","year":"2023","unstructured":"Pan, Z. et al. IL2RA+VSIG4+ tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer. Biochim. Biophys. Acta Mol. Basis Dis. 1869 (1), 166591. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166591 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"83719_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.surg.2019.02.024","volume":"167","author":"NG Nicolson","year":"2020","unstructured":"Nicolson, N. G., Brown, T. C., Korah, R. & Carling, T. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis. Surgery 167 (1), 66\u201372. https:\/\/doi.org\/10.1016\/j.surg.2019.02.024 (2020).","journal-title":"Surgery"},{"issue":"10","key":"83719_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov, Y. E. & Nikiforova, M. N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7 (10), 569\u2013580. https:\/\/doi.org\/10.1038\/nrendo.2011.142 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"83719_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Hong, W. & Wei, X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J. Hematol. Oncol. 15 (1), 129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"83719_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"83719_CR36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/08820139.2023.2268656","volume":"52","author":"Y Tao","year":"2023","unstructured":"Tao, Y., Li, P., Feng, C. & Cao, Y. New insights into immune cells and immunotherapy for thyroid cancer. Immunol. Investig. 52 (8), 1039\u20131064. https:\/\/doi.org\/10.1080\/08820139.2023.2268656 (2023).","journal-title":"Immunol. Investig."},{"issue":"4","key":"83719_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12012","volume":"40","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Yang, M., Wang, S., Li, X. & Sun, Y. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun. (Lond.) 40 (4), 154\u2013166. https:\/\/doi.org\/10.1002\/cac2.12012 (2020).","journal-title":"Cancer Commun. (Lond.)"},{"issue":"3","key":"83719_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41 (3), 374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016 (2023).","journal-title":"Cancer Cell"},{"issue":"1","key":"83719_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao, X. et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol. Cancer 20 (1), 131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1 (2021).","journal-title":"Mol. Cancer"},{"issue":"1","key":"83719_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","volume":"38","author":"A Rotte","year":"2019","unstructured":"Rotte, A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J. Exp. Clin. Cancer Res. 38 (1), 255. https:\/\/doi.org\/10.1186\/s13046-019-1259-z (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"83719_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-018-0378-y","volume":"6","author":"PC Iyer","year":"2018","unstructured":"Iyer, P. C. et al. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J. Immunother. Cancer 6 (1), 68. https:\/\/doi.org\/10.1186\/s40425-018-0378-y (2018).","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"83719_CR42","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1089\/thy.2014.0134","volume":"24","author":"TE Angell","year":"2014","unstructured":"Angell, T. E. et al. BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration. Thyroid 24 (9), 1385\u20131393. https:\/\/doi.org\/10.1089\/thy.2014.0134 (2014).","journal-title":"Thyroid"},{"key":"83719_CR43","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2147\/DDDT.S244516","volume":"14","author":"GF Xie","year":"2020","unstructured":"Xie, G. F. et al. High ACTN1 is associated with poor prognosis, and ACTN1 silencing suppresses cell proliferation and metastasis in oral squamous cell carcinoma. Drug Des. Dev. Ther. 14, 1717\u20131727. https:\/\/doi.org\/10.2147\/DDDT.S244516 (2020).","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"83719_CR44","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186 (8), 1564\u20131579. https:\/\/doi.org\/10.1016\/j.cell.2023.03.003 (2023).","journal-title":"Cell"},{"issue":"24","key":"83719_CR45","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.3390\/cancers15245880","volume":"15","author":"QY Gu","year":"2023","unstructured":"Gu, Q. Y. et al. LLGL2 inhibits ovarian cancer metastasis by regulating cytoskeleton remodeling via ACTN1. Cancers (Basel) 15 (24), 5880. https:\/\/doi.org\/10.3390\/cancers15245880 (2023).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"83719_CR46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29 (3), 212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001 (2019).","journal-title":"Trends Cell Biol."},{"issue":"1","key":"83719_CR47","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1080\/21655979.2021","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. \u03b1-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT\/GSK3\u03b2\/\u03b2-catenin pathway. Bioengineered 12 (1), 5688\u20135704. https:\/\/doi.org\/10.1080\/21655979.2021 (2021).","journal-title":"Bioengineered"},{"issue":"1","key":"83719_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22 (1), 138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6 (2023).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83719-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:08:26Z","timestamp":1735643306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83719-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["83719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83719-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Affiliated Hospital of Guizhou Medical University approved all the experiments. All the patients had signed informed consents. We confirm that all methods were performed in accordance with the relevant guidelines and regulations. Animal studies were reported according to the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"32060"}}